Screener
AbbVie ABBV Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: AbbVie’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 8, 2026, 12:28 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001551152-26-000017
FAQ
- What is AbbVie's other non-current liabilities?
- AbbVie (ABBV) reported other non-current liabilities of $34.11B in Q1 2026.
- How has AbbVie's other non-current liabilities changed year-over-year?
- AbbVie's other non-current liabilities increased by 9.4% year-over-year, from $31.19B to $34.11B.
- What is the long-term trend for AbbVie's other non-current liabilities?
- Over 5 years (2020 to 2025), AbbVie's other non-current liabilities has grown at a 3.4% compound annual growth rate (CAGR), from $27.61B to $32.57B.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about AbbVie's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude